Joshua E. French
- T. 617.439.2099
- F. 617.310.9099
- E. jfrench@nutter.com
- Download full bio
Overview
Joshua E. French is a partner in Nutter’s Corporate and Transactions Department. He focuses his practice on advising clients in mergers and acquisitions, debt and equity finance, corporate governance, business succession planning, and formation matters.
Clients in all stages of their business life cycle engage Josh to serve as their outside general counsel. He has extensive experience advising privately-held emerging and middle-market companies, as well as family-owned and generational businesses, on navigating corporate formation, succession planning, fundraising, and liquidity events. Senior management at companies in a wide range of industries work closely with Josh to solve their complex business challenges. Additionally, Josh serves as lead counsel to venture capital investors in connection with venture and growth equity investments in operating companies as well as the management of such investors’ portfolio companies.
Notable Experience and Client Impact
- Represented CRIO, Inc., a leading provider of eSource and other eClinical technologies, in a significant investment from The Riverside Company, a global growth oriented private equity firm.
- Represented CHEORS, a health economics and outcomes research (HEOR) provider for the pharmaceutical, biotechnology, and medical device industries in its sale to Pharm Alliance, a portfolio company of Waud Capital Partners.
- Represented Vestigo Ventures in 30 investments in transformative FinTech companies with an aggregate deal value approximating $80 million.
- Represented iResearch, a leading multi-specialty clinical research center with locations in Decatur, GA and Savannah, GA, in connection with its acquisition by CenExel.
- Represented Analog Devices, a multinational semiconductor company specializing in data conversion, signal processing, and power management technology, in the sale of its CATV amplifier business to Scientific Components Corporation (d/b/a Mini-Circuits).
- Represented Shepley Wood Products, the premier building supply company for Cape Cod, Nantucket, and Southeastern Massachusetts, in its acquisition by Kodiak Building Partners, a Denver-based building products distribution platform.
-
Advised Abveris (formally known as AbX Biologics, Inc.), a privately-held in vivo antibody discovery services company, in connection with its acquisition by Twist Bioscience Corporation (NASDAQ: TWST), a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology.
- Represented Lallemand USA in the acquisition of Scott Laboratories, a leading supplier of fermentation and filtration products in the wine and specialty beverage industry.
- Represented Innovation Associates, a majority family-owned business spanning multiple generations that is a leading provider of software-enabled pharmacy automation solutions, in its acquisition by a consortium of private equity investors.
- Represented Globe Composite Solutions, a supplier of engineered composite products for naval, defense and industrial customers in its acquisition by ESCO Technologies (NYSE: ESE).
- Represented Ce3, a clinical research organization providing early phase clinical development services to the biotechnology industry, in the sale of its business to Catalyst Clinical Research.
- Represented Location Inc., a leading provider of geographic data science and predictive, location-based analytics, to its strategic partner CoreLogic (NYSE: CLGX).
- Represented T3 Expo, LLC, the general contractor for creating shareable moments™ for tradeshows and corporate events, in its financing with MB Capital Fund IV, LLC.
- Represented a leading provider of owner’s project management services in the New England region in connection with its acquisition.
- Represented a leading single-source provider of fluid handling solutions for high purity applications in connection with its acquisition by a distributor of laboratory products.
- Represented a developer of scheduling and optimization software for an adaptive ecosystem for high-performance and cloud computing systems in connection with a variety of general corporate matters and financings, and its sale to an enterprise software company.
- Represented Audley Travel US, Inc., a subsidiary of a leading private equity backed UK travel service, in its negotiation of a major credit facility with Barclays Bank.
- Represented a provider of nanocrystalline calcium-phosphate-based biomaterials that promote the repair and regeneration of damaged bone in its $60 million acquisition by a leading medical devices company.
- Advised an electrical company in its acquisition by a private equity backed leader in the utilities industry.
- Represented a provider of water hauling, disposal, and acid services for oil and gas exploration and production companies in its $50 million sale to a publicly-traded closed-end investment company.
Josh has served as a judge of the Venture Capital Investment Competition, a business plan competition in which students are the investors and entrepreneurs pitch to them. He has presented on financing, corporate law, and equity at TiE ScaleUp and TechSandbox, programs that help entrepreneurs grow their businesses. He is also a member of the Boston Bar Association.
Josh is a member of the Board of Directors of Exit Planning Exchange (XPX), as well as the chairperson of the Emerging Professionals Committee.
Josh is also a committee member for the National MS Society’s annual Climb to the Top event, in which participants ascend more than 1,000 stairs to raise funds for MS research.
Prior to joining Nutter, Josh was a senior attorney at a prominent Massachusetts law firm.
Read More
Experience
Experience
News & Insights
News
Speaking Engagements
Publications
Education & Admissions
Education
Boston College Law School, J.D., magna cum laude
Duke University, B.A.
Admissions
- Massachusetts
Practices
Industries
In the Community
Josh is a committee member for the National MS Society’s annual Climb to the Top event, in which participants ascend more than 1,000 stairs to raise funds for MS research.